COVID-19 Impact on Global Antiserum Market Insights, Forecast to 2026
Antiserum market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiserum market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antiserum market is segmented into
The Antiserum market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antiserum market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antiserum Market Share Analysis
Antiserum market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antiserum business, the date to enter into the Antiserum market, Antiserum product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Antiserum market is segmented into
- Antitoxin Serum
- Antibacterial Serum
- Antiviral Serum
- Anti-Rh Serum
- Laboratory
- Clinical
- Other
The Antiserum market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antiserum market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antiserum Market Share Analysis
Antiserum market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antiserum business, the date to enter into the Antiserum market, Antiserum product introduction, recent developments, etc.
The major vendors covered:
- Charles River
- SSI Diagnostica
- BD
- GD Animal Health
- Novacyt Group
- OriGene Technologies
- Bethyl Laboratories
- FUJIFILM Wako Pure Chemical Corporation
- Thermo Scientific
- Bio-Rad
1 STUDY COVERAGE
1.1 Antiserum Product Introduction
1.2 Market Segments
1.3 Key Antiserum Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antiserum Market Size Growth Rate by Type
1.4.2 Antitoxin Serum
1.4.3 Antibacterial Serum
1.4.4 Antiviral Serum
1.4.5 Anti-Rh Serum
1.5 Market by Application
1.5.1 Global Antiserum Market Size Growth Rate by Application
1.5.2 Laboratory
1.5.3 Clinical
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Antiserum Industry Impact
1.6.1 How the Covid-19 is Affecting the Antiserum Industry
1.6.1.1 Antiserum Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antiserum Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antiserum Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Antiserum Market Size Estimates and Forecasts
2.1.1 Global Antiserum Revenue 2015-2026
2.1.2 Global Antiserum Sales 2015-2026
2.2 Antiserum Market Size by Region: 2020 Versus 2026
2.2.1 Global Antiserum Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antiserum Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTISERUM COMPETITOR LANDSCAPE BY PLAYERS
3.1 Antiserum Sales by Manufacturers
3.1.1 Antiserum Sales by Manufacturers (2015-2020)
3.1.2 Antiserum Sales Market Share by Manufacturers (2015-2020)
3.2 Antiserum Revenue by Manufacturers
3.2.1 Antiserum Revenue by Manufacturers (2015-2020)
3.2.2 Antiserum Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antiserum Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2019
3.2.5 Global Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antiserum Price by Manufacturers
3.4 Antiserum Manufacturing Base Distribution, Product Types
3.4.1 Antiserum Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antiserum Product Type
3.4.3 Date of International Manufacturers Enter into Antiserum Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Antiserum Market Size by Type (2015-2020)
4.1.1 Global Antiserum Sales by Type (2015-2020)
4.1.2 Global Antiserum Revenue by Type (2015-2020)
4.1.3 Antiserum Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antiserum Market Size Forecast by Type (2021-2026)
4.2.1 Global Antiserum Sales Forecast by Type (2021-2026)
4.2.2 Global Antiserum Revenue Forecast by Type (2021-2026)
4.2.3 Antiserum Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antiserum Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Antiserum Market Size by Application (2015-2020)
5.1.1 Global Antiserum Sales by Application (2015-2020)
5.1.2 Global Antiserum Revenue by Application (2015-2020)
5.1.3 Antiserum Price by Application (2015-2020)
5.2 Antiserum Market Size Forecast by Application (2021-2026)
5.2.1 Global Antiserum Sales Forecast by Application (2021-2026)
5.2.2 Global Antiserum Revenue Forecast by Application (2021-2026)
5.2.3 Global Antiserum Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Antiserum by Country
6.1.1 North America Antiserum Sales by Country
6.1.2 North America Antiserum Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antiserum Market Facts & Figures by Type
6.3 North America Antiserum Market Facts & Figures by Application
7 EUROPE
7.1 Europe Antiserum by Country
7.1.1 Europe Antiserum Sales by Country
7.1.2 Europe Antiserum Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antiserum Market Facts & Figures by Type
7.3 Europe Antiserum Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Antiserum by Region
8.1.1 Asia Pacific Antiserum Sales by Region
8.1.2 Asia Pacific Antiserum Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antiserum Market Facts & Figures by Type
8.3 Asia Pacific Antiserum Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Antiserum by Country
9.1.1 Latin America Antiserum Sales by Country
9.1.2 Latin America Antiserum Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antiserum Market Facts & Figures by Type
9.3 Central & South America Antiserum Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Antiserum by Country
10.1.1 Middle East and Africa Antiserum Sales by Country
10.1.2 Middle East and Africa Antiserum Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antiserum Market Facts & Figures by Type
10.3 Middle East and Africa Antiserum Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Description, Business Overview and Total Revenue
11.1.3 Charles River Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Charles River Antiserum Products Offered
11.1.5 Charles River Recent Development
11.2 SSI Diagnostica
11.2.1 SSI Diagnostica Corporation Information
11.2.2 SSI Diagnostica Description, Business Overview and Total Revenue
11.2.3 SSI Diagnostica Sales, Revenue and Gross Margin (2015-2020)
11.2.4 SSI Diagnostica Antiserum Products Offered
11.2.5 SSI Diagnostica Recent Development
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Description, Business Overview and Total Revenue
11.3.3 BD Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BD Antiserum Products Offered
11.3.5 BD Recent Development
11.4 GD Animal Health
11.4.1 GD Animal Health Corporation Information
11.4.2 GD Animal Health Description, Business Overview and Total Revenue
11.4.3 GD Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GD Animal Health Antiserum Products Offered
11.4.5 GD Animal Health Recent Development
11.5 Novacyt Group
11.5.1 Novacyt Group Corporation Information
11.5.2 Novacyt Group Description, Business Overview and Total Revenue
11.5.3 Novacyt Group Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novacyt Group Antiserum Products Offered
11.5.5 Novacyt Group Recent Development
11.6 OriGene Technologies
11.6.1 OriGene Technologies Corporation Information
11.6.2 OriGene Technologies Description, Business Overview and Total Revenue
11.6.3 OriGene Technologies Sales, Revenue and Gross Margin (2015-2020)
11.6.4 OriGene Technologies Antiserum Products Offered
11.6.5 OriGene Technologies Recent Development
11.7 Bethyl Laboratories
11.7.1 Bethyl Laboratories Corporation Information
11.7.2 Bethyl Laboratories Description, Business Overview and Total Revenue
11.7.3 Bethyl Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bethyl Laboratories Antiserum Products Offered
11.7.5 Bethyl Laboratories Recent Development
11.8 FUJIFILM Wako Pure Chemical Corporation
11.8.1 FUJIFILM Wako Pure Chemical Corporation Corporation Information
11.8.2 FUJIFILM Wako Pure Chemical Corporation Description, Business Overview and Total Revenue
11.8.3 FUJIFILM Wako Pure Chemical Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 FUJIFILM Wako Pure Chemical Corporation Antiserum Products Offered
11.8.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
11.9 Thermo Scientific
11.9.1 Thermo Scientific Corporation Information
11.9.2 Thermo Scientific Description, Business Overview and Total Revenue
11.9.3 Thermo Scientific Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Thermo Scientific Antiserum Products Offered
11.9.5 Thermo Scientific Recent Development
11.10 Bio-Rad
11.10.1 Bio-Rad Corporation Information
11.10.2 Bio-Rad Description, Business Overview and Total Revenue
11.10.3 Bio-Rad Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bio-Rad Antiserum Products Offered
11.10.5 Bio-Rad Recent Development
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Description, Business Overview and Total Revenue
11.1.3 Charles River Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Charles River Antiserum Products Offered
11.1.5 Charles River Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Antiserum Market Estimates and Projections by Region
12.1.1 Global Antiserum Sales Forecast by Regions 2021-2026
12.1.2 Global Antiserum Revenue Forecast by Regions 2021-2026
12.2 North America Antiserum Market Size Forecast (2021-2026)
12.2.1 North America: Antiserum Sales Forecast (2021-2026)
12.2.2 North America: Antiserum Revenue Forecast (2021-2026)
12.2.3 North America: Antiserum Market Size Forecast by Country (2021-2026)
12.3 Europe Antiserum Market Size Forecast (2021-2026)
12.3.1 Europe: Antiserum Sales Forecast (2021-2026)
12.3.2 Europe: Antiserum Revenue Forecast (2021-2026)
12.3.3 Europe: Antiserum Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antiserum Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antiserum Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antiserum Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antiserum Market Size Forecast by Region (2021-2026)
12.5 Latin America Antiserum Market Size Forecast (2021-2026)
12.5.1 Latin America: Antiserum Sales Forecast (2021-2026)
12.5.2 Latin America: Antiserum Revenue Forecast (2021-2026)
12.5.3 Latin America: Antiserum Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antiserum Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antiserum Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antiserum Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antiserum Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antiserum Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Antiserum Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Antiserum Product Introduction
1.2 Market Segments
1.3 Key Antiserum Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antiserum Market Size Growth Rate by Type
1.4.2 Antitoxin Serum
1.4.3 Antibacterial Serum
1.4.4 Antiviral Serum
1.4.5 Anti-Rh Serum
1.5 Market by Application
1.5.1 Global Antiserum Market Size Growth Rate by Application
1.5.2 Laboratory
1.5.3 Clinical
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Antiserum Industry Impact
1.6.1 How the Covid-19 is Affecting the Antiserum Industry
1.6.1.1 Antiserum Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antiserum Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antiserum Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Antiserum Market Size Estimates and Forecasts
2.1.1 Global Antiserum Revenue 2015-2026
2.1.2 Global Antiserum Sales 2015-2026
2.2 Antiserum Market Size by Region: 2020 Versus 2026
2.2.1 Global Antiserum Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antiserum Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTISERUM COMPETITOR LANDSCAPE BY PLAYERS
3.1 Antiserum Sales by Manufacturers
3.1.1 Antiserum Sales by Manufacturers (2015-2020)
3.1.2 Antiserum Sales Market Share by Manufacturers (2015-2020)
3.2 Antiserum Revenue by Manufacturers
3.2.1 Antiserum Revenue by Manufacturers (2015-2020)
3.2.2 Antiserum Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antiserum Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2019
3.2.5 Global Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antiserum Price by Manufacturers
3.4 Antiserum Manufacturing Base Distribution, Product Types
3.4.1 Antiserum Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antiserum Product Type
3.4.3 Date of International Manufacturers Enter into Antiserum Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Antiserum Market Size by Type (2015-2020)
4.1.1 Global Antiserum Sales by Type (2015-2020)
4.1.2 Global Antiserum Revenue by Type (2015-2020)
4.1.3 Antiserum Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antiserum Market Size Forecast by Type (2021-2026)
4.2.1 Global Antiserum Sales Forecast by Type (2021-2026)
4.2.2 Global Antiserum Revenue Forecast by Type (2021-2026)
4.2.3 Antiserum Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antiserum Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Antiserum Market Size by Application (2015-2020)
5.1.1 Global Antiserum Sales by Application (2015-2020)
5.1.2 Global Antiserum Revenue by Application (2015-2020)
5.1.3 Antiserum Price by Application (2015-2020)
5.2 Antiserum Market Size Forecast by Application (2021-2026)
5.2.1 Global Antiserum Sales Forecast by Application (2021-2026)
5.2.2 Global Antiserum Revenue Forecast by Application (2021-2026)
5.2.3 Global Antiserum Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Antiserum by Country
6.1.1 North America Antiserum Sales by Country
6.1.2 North America Antiserum Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antiserum Market Facts & Figures by Type
6.3 North America Antiserum Market Facts & Figures by Application
7 EUROPE
7.1 Europe Antiserum by Country
7.1.1 Europe Antiserum Sales by Country
7.1.2 Europe Antiserum Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antiserum Market Facts & Figures by Type
7.3 Europe Antiserum Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Antiserum by Region
8.1.1 Asia Pacific Antiserum Sales by Region
8.1.2 Asia Pacific Antiserum Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antiserum Market Facts & Figures by Type
8.3 Asia Pacific Antiserum Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Antiserum by Country
9.1.1 Latin America Antiserum Sales by Country
9.1.2 Latin America Antiserum Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antiserum Market Facts & Figures by Type
9.3 Central & South America Antiserum Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Antiserum by Country
10.1.1 Middle East and Africa Antiserum Sales by Country
10.1.2 Middle East and Africa Antiserum Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antiserum Market Facts & Figures by Type
10.3 Middle East and Africa Antiserum Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Description, Business Overview and Total Revenue
11.1.3 Charles River Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Charles River Antiserum Products Offered
11.1.5 Charles River Recent Development
11.2 SSI Diagnostica
11.2.1 SSI Diagnostica Corporation Information
11.2.2 SSI Diagnostica Description, Business Overview and Total Revenue
11.2.3 SSI Diagnostica Sales, Revenue and Gross Margin (2015-2020)
11.2.4 SSI Diagnostica Antiserum Products Offered
11.2.5 SSI Diagnostica Recent Development
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Description, Business Overview and Total Revenue
11.3.3 BD Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BD Antiserum Products Offered
11.3.5 BD Recent Development
11.4 GD Animal Health
11.4.1 GD Animal Health Corporation Information
11.4.2 GD Animal Health Description, Business Overview and Total Revenue
11.4.3 GD Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GD Animal Health Antiserum Products Offered
11.4.5 GD Animal Health Recent Development
11.5 Novacyt Group
11.5.1 Novacyt Group Corporation Information
11.5.2 Novacyt Group Description, Business Overview and Total Revenue
11.5.3 Novacyt Group Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novacyt Group Antiserum Products Offered
11.5.5 Novacyt Group Recent Development
11.6 OriGene Technologies
11.6.1 OriGene Technologies Corporation Information
11.6.2 OriGene Technologies Description, Business Overview and Total Revenue
11.6.3 OriGene Technologies Sales, Revenue and Gross Margin (2015-2020)
11.6.4 OriGene Technologies Antiserum Products Offered
11.6.5 OriGene Technologies Recent Development
11.7 Bethyl Laboratories
11.7.1 Bethyl Laboratories Corporation Information
11.7.2 Bethyl Laboratories Description, Business Overview and Total Revenue
11.7.3 Bethyl Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bethyl Laboratories Antiserum Products Offered
11.7.5 Bethyl Laboratories Recent Development
11.8 FUJIFILM Wako Pure Chemical Corporation
11.8.1 FUJIFILM Wako Pure Chemical Corporation Corporation Information
11.8.2 FUJIFILM Wako Pure Chemical Corporation Description, Business Overview and Total Revenue
11.8.3 FUJIFILM Wako Pure Chemical Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 FUJIFILM Wako Pure Chemical Corporation Antiserum Products Offered
11.8.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
11.9 Thermo Scientific
11.9.1 Thermo Scientific Corporation Information
11.9.2 Thermo Scientific Description, Business Overview and Total Revenue
11.9.3 Thermo Scientific Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Thermo Scientific Antiserum Products Offered
11.9.5 Thermo Scientific Recent Development
11.10 Bio-Rad
11.10.1 Bio-Rad Corporation Information
11.10.2 Bio-Rad Description, Business Overview and Total Revenue
11.10.3 Bio-Rad Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bio-Rad Antiserum Products Offered
11.10.5 Bio-Rad Recent Development
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Description, Business Overview and Total Revenue
11.1.3 Charles River Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Charles River Antiserum Products Offered
11.1.5 Charles River Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Antiserum Market Estimates and Projections by Region
12.1.1 Global Antiserum Sales Forecast by Regions 2021-2026
12.1.2 Global Antiserum Revenue Forecast by Regions 2021-2026
12.2 North America Antiserum Market Size Forecast (2021-2026)
12.2.1 North America: Antiserum Sales Forecast (2021-2026)
12.2.2 North America: Antiserum Revenue Forecast (2021-2026)
12.2.3 North America: Antiserum Market Size Forecast by Country (2021-2026)
12.3 Europe Antiserum Market Size Forecast (2021-2026)
12.3.1 Europe: Antiserum Sales Forecast (2021-2026)
12.3.2 Europe: Antiserum Revenue Forecast (2021-2026)
12.3.3 Europe: Antiserum Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antiserum Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antiserum Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antiserum Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antiserum Market Size Forecast by Region (2021-2026)
12.5 Latin America Antiserum Market Size Forecast (2021-2026)
12.5.1 Latin America: Antiserum Sales Forecast (2021-2026)
12.5.2 Latin America: Antiserum Revenue Forecast (2021-2026)
12.5.3 Latin America: Antiserum Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antiserum Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antiserum Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antiserum Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antiserum Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antiserum Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Antiserum Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Antiserum Market Segments
Table 2. Ranking of Global Top Antiserum Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antiserum Market Size Growth Rate by Type 2020-2026 (K L) & (US$ Million)
Table 4. Major Manufacturers of Antitoxin Serum
Table 5. Major Manufacturers of Antibacterial Serum
Table 6. Major Manufacturers of Antiviral Serum
Table 7. Major Manufacturers of Anti-Rh Serum
Table 8. COVID-19 Impact Global Market: (Four Antiserum Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Antiserum Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Antiserum Players to Combat Covid-19 Impact
Table 13. Global Antiserum Market Size Growth Rate by Application 2020-2026 (K L)
Table 14. Global Antiserum Market Size by Region (K L) & (US$ Million): 2020 VS 2026
Table 15. Global Antiserum Sales by Regions 2015-2020 (K L)
Table 16. Global Antiserum Sales Market Share by Regions (2015-2020)
Table 17. Global Antiserum Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Antiserum Sales by Manufacturers (2015-2020) (K L)
Table 19. Global Antiserum Sales Share by Manufacturers (2015-2020)
Table 20. Global Antiserum Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Antiserum by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiserum as of 2019)
Table 22. Antiserum Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Antiserum Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Antiserum Price (2015-2020) (USD/L)
Table 25. Antiserum Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Antiserum Product Type
Table 27. Date of International Manufacturers Enter into Antiserum Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Antiserum Sales by Type (2015-2020) (K L)
Table 30. Global Antiserum Sales Share by Type (2015-2020)
Table 31. Global Antiserum Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Antiserum Revenue Share by Type (2015-2020)
Table 33. Antiserum Average Selling Price (ASP) by Type 2015-2020 (USD/L)
Table 34. Global Antiserum Sales by Application (2015-2020) (K L)
Table 35. Global Antiserum Sales Share by Application (2015-2020)
Table 36. North America Antiserum Sales by Country (2015-2020) (K L)
Table 37. North America Antiserum Sales Market Share by Country (2015-2020)
Table 38. North America Antiserum Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Antiserum Revenue Market Share by Country (2015-2020)
Table 40. North America Antiserum Sales by Type (2015-2020) (K L)
Table 41. North America Antiserum Sales Market Share by Type (2015-2020)
Table 42. North America Antiserum Sales by Application (2015-2020) (K L)
Table 43. North America Antiserum Sales Market Share by Application (2015-2020)
Table 44. Europe Antiserum Sales by Country (2015-2020) (K L)
Table 45. Europe Antiserum Sales Market Share by Country (2015-2020)
Table 46. Europe Antiserum Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Antiserum Revenue Market Share by Country (2015-2020)
Table 48. Europe Antiserum Sales by Type (2015-2020) (K L)
Table 49. Europe Antiserum Sales Market Share by Type (2015-2020)
Table 50. Europe Antiserum Sales by Application (2015-2020) (K L)
Table 51. Europe Antiserum Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Antiserum Sales by Region (2015-2020) (K L)
Table 53. Asia Pacific Antiserum Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Antiserum Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Antiserum Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Antiserum Sales by Type (2015-2020) (K L)
Table 57. Asia Pacific Antiserum Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Antiserum Sales by Application (2015-2020) (K L)
Table 59. Asia Pacific Antiserum Sales Market Share by Application (2015-2020)
Table 60. Latin America Antiserum Sales by Country (2015-2020) (K L)
Table 61. Latin America Antiserum Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Antiserum Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Antiserum Revenue Market Share by Country (2015-2020)
Table 64. Latin America Antiserum Sales by Type (2015-2020) (K L)
Table 65. Latin America Antiserum Sales Market Share by Type (2015-2020)
Table 66. Latin America Antiserum Sales by Application (2015-2020) (K L)
Table 67. Latin America Antiserum Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Antiserum Sales by Country (2015-2020) (K L)
Table 69. Middle East and Africa Antiserum Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Antiserum Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Antiserum Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Antiserum Sales by Type (2015-2020) (K L)
Table 73. Middle East and Africa Antiserum Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Antiserum Sales by Application (2015-2020) (K L)
Table 75. Middle East and Africa Antiserum Sales Market Share by Application (2015-2020)
Table 76. Charles River Corporation Information
Table 77. Charles River Description and Major Businesses
Table 78. Charles River Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 79. Charles River Product
Table 80. Charles River Recent Development
Table 81. SSI Diagnostica Corporation Information
Table 82. SSI Diagnostica Description and Major Businesses
Table 83. SSI Diagnostica Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 84. SSI Diagnostica Product
Table 85. SSI Diagnostica Recent Development
Table 86. BD Corporation Information
Table 87. BD Description and Major Businesses
Table 88. BD Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 89. BD Product
Table 90. BD Recent Development
Table 91. GD Animal Health Corporation Information
Table 92. GD Animal Health Description and Major Businesses
Table 93. GD Animal Health Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 94. GD Animal Health Product
Table 95. GD Animal Health Recent Development
Table 96. Novacyt Group Corporation Information
Table 97. Novacyt Group Description and Major Businesses
Table 98. Novacyt Group Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 99. Novacyt Group Product
Table 100. Novacyt Group Recent Development
Table 101. OriGene Technologies Corporation Information
Table 102. OriGene Technologies Description and Major Businesses
Table 103. OriGene Technologies Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 104. OriGene Technologies Product
Table 105. OriGene Technologies Recent Development
Table 106. Bethyl Laboratories Corporation Information
Table 107. Bethyl Laboratories Description and Major Businesses
Table 108. Bethyl Laboratories Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 109. Bethyl Laboratories Product
Table 110. Bethyl Laboratories Recent Development
Table 111. FUJIFILM Wako Pure Chemical Corporation Corporation Information
Table 112. FUJIFILM Wako Pure Chemical Corporation Description and Major Businesses
Table 113. FUJIFILM Wako Pure Chemical Corporation Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 114. FUJIFILM Wako Pure Chemical Corporation Product
Table 115. FUJIFILM Wako Pure Chemical Corporation Recent Development
Table 116. Thermo Scientific Corporation Information
Table 117. Thermo Scientific Description and Major Businesses
Table 118. Thermo Scientific Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 119. Thermo Scientific Product
Table 120. Thermo Scientific Recent Development
Table 121. Bio-Rad Corporation Information
Table 122. Bio-Rad Description and Major Businesses
Table 123. Bio-Rad Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 124. Bio-Rad Product
Table 125. Bio-Rad Recent Development
Table 126. Global Antiserum Sales Forecast by Regions (2021-2026) (K L)
Table 127. Global Antiserum Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Antiserum Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Antiserum Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Antiserum Sales Forecast by Country (2021-2026) (K L)
Table 131. North America: Antiserum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Antiserum Sales Forecast by Country (2021-2026) (K L)
Table 133. Europe: Antiserum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Antiserum Sales Forecast by Region (2021-2026) (K L)
Table 135. Asia Pacific: Antiserum Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Antiserum Sales Forecast by Country (2021-2026) (K L)
Table 137. Latin America: Antiserum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Antiserum Sales Forecast by Country (2021-2026) (K L)
Table 139. Middle East and Africa: Antiserum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Antiserum Players
Table 144. Antiserum Customers List
Table 145. Antiserum Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 1. Antiserum Market Segments
Table 2. Ranking of Global Top Antiserum Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antiserum Market Size Growth Rate by Type 2020-2026 (K L) & (US$ Million)
Table 4. Major Manufacturers of Antitoxin Serum
Table 5. Major Manufacturers of Antibacterial Serum
Table 6. Major Manufacturers of Antiviral Serum
Table 7. Major Manufacturers of Anti-Rh Serum
Table 8. COVID-19 Impact Global Market: (Four Antiserum Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Antiserum Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Antiserum Players to Combat Covid-19 Impact
Table 13. Global Antiserum Market Size Growth Rate by Application 2020-2026 (K L)
Table 14. Global Antiserum Market Size by Region (K L) & (US$ Million): 2020 VS 2026
Table 15. Global Antiserum Sales by Regions 2015-2020 (K L)
Table 16. Global Antiserum Sales Market Share by Regions (2015-2020)
Table 17. Global Antiserum Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Antiserum Sales by Manufacturers (2015-2020) (K L)
Table 19. Global Antiserum Sales Share by Manufacturers (2015-2020)
Table 20. Global Antiserum Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Antiserum by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiserum as of 2019)
Table 22. Antiserum Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Antiserum Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Antiserum Price (2015-2020) (USD/L)
Table 25. Antiserum Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Antiserum Product Type
Table 27. Date of International Manufacturers Enter into Antiserum Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Antiserum Sales by Type (2015-2020) (K L)
Table 30. Global Antiserum Sales Share by Type (2015-2020)
Table 31. Global Antiserum Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Antiserum Revenue Share by Type (2015-2020)
Table 33. Antiserum Average Selling Price (ASP) by Type 2015-2020 (USD/L)
Table 34. Global Antiserum Sales by Application (2015-2020) (K L)
Table 35. Global Antiserum Sales Share by Application (2015-2020)
Table 36. North America Antiserum Sales by Country (2015-2020) (K L)
Table 37. North America Antiserum Sales Market Share by Country (2015-2020)
Table 38. North America Antiserum Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Antiserum Revenue Market Share by Country (2015-2020)
Table 40. North America Antiserum Sales by Type (2015-2020) (K L)
Table 41. North America Antiserum Sales Market Share by Type (2015-2020)
Table 42. North America Antiserum Sales by Application (2015-2020) (K L)
Table 43. North America Antiserum Sales Market Share by Application (2015-2020)
Table 44. Europe Antiserum Sales by Country (2015-2020) (K L)
Table 45. Europe Antiserum Sales Market Share by Country (2015-2020)
Table 46. Europe Antiserum Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Antiserum Revenue Market Share by Country (2015-2020)
Table 48. Europe Antiserum Sales by Type (2015-2020) (K L)
Table 49. Europe Antiserum Sales Market Share by Type (2015-2020)
Table 50. Europe Antiserum Sales by Application (2015-2020) (K L)
Table 51. Europe Antiserum Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Antiserum Sales by Region (2015-2020) (K L)
Table 53. Asia Pacific Antiserum Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Antiserum Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Antiserum Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Antiserum Sales by Type (2015-2020) (K L)
Table 57. Asia Pacific Antiserum Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Antiserum Sales by Application (2015-2020) (K L)
Table 59. Asia Pacific Antiserum Sales Market Share by Application (2015-2020)
Table 60. Latin America Antiserum Sales by Country (2015-2020) (K L)
Table 61. Latin America Antiserum Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Antiserum Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Antiserum Revenue Market Share by Country (2015-2020)
Table 64. Latin America Antiserum Sales by Type (2015-2020) (K L)
Table 65. Latin America Antiserum Sales Market Share by Type (2015-2020)
Table 66. Latin America Antiserum Sales by Application (2015-2020) (K L)
Table 67. Latin America Antiserum Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Antiserum Sales by Country (2015-2020) (K L)
Table 69. Middle East and Africa Antiserum Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Antiserum Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Antiserum Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Antiserum Sales by Type (2015-2020) (K L)
Table 73. Middle East and Africa Antiserum Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Antiserum Sales by Application (2015-2020) (K L)
Table 75. Middle East and Africa Antiserum Sales Market Share by Application (2015-2020)
Table 76. Charles River Corporation Information
Table 77. Charles River Description and Major Businesses
Table 78. Charles River Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 79. Charles River Product
Table 80. Charles River Recent Development
Table 81. SSI Diagnostica Corporation Information
Table 82. SSI Diagnostica Description and Major Businesses
Table 83. SSI Diagnostica Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 84. SSI Diagnostica Product
Table 85. SSI Diagnostica Recent Development
Table 86. BD Corporation Information
Table 87. BD Description and Major Businesses
Table 88. BD Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 89. BD Product
Table 90. BD Recent Development
Table 91. GD Animal Health Corporation Information
Table 92. GD Animal Health Description and Major Businesses
Table 93. GD Animal Health Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 94. GD Animal Health Product
Table 95. GD Animal Health Recent Development
Table 96. Novacyt Group Corporation Information
Table 97. Novacyt Group Description and Major Businesses
Table 98. Novacyt Group Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 99. Novacyt Group Product
Table 100. Novacyt Group Recent Development
Table 101. OriGene Technologies Corporation Information
Table 102. OriGene Technologies Description and Major Businesses
Table 103. OriGene Technologies Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 104. OriGene Technologies Product
Table 105. OriGene Technologies Recent Development
Table 106. Bethyl Laboratories Corporation Information
Table 107. Bethyl Laboratories Description and Major Businesses
Table 108. Bethyl Laboratories Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 109. Bethyl Laboratories Product
Table 110. Bethyl Laboratories Recent Development
Table 111. FUJIFILM Wako Pure Chemical Corporation Corporation Information
Table 112. FUJIFILM Wako Pure Chemical Corporation Description and Major Businesses
Table 113. FUJIFILM Wako Pure Chemical Corporation Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 114. FUJIFILM Wako Pure Chemical Corporation Product
Table 115. FUJIFILM Wako Pure Chemical Corporation Recent Development
Table 116. Thermo Scientific Corporation Information
Table 117. Thermo Scientific Description and Major Businesses
Table 118. Thermo Scientific Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 119. Thermo Scientific Product
Table 120. Thermo Scientific Recent Development
Table 121. Bio-Rad Corporation Information
Table 122. Bio-Rad Description and Major Businesses
Table 123. Bio-Rad Antiserum Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 124. Bio-Rad Product
Table 125. Bio-Rad Recent Development
Table 126. Global Antiserum Sales Forecast by Regions (2021-2026) (K L)
Table 127. Global Antiserum Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Antiserum Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Antiserum Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Antiserum Sales Forecast by Country (2021-2026) (K L)
Table 131. North America: Antiserum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Antiserum Sales Forecast by Country (2021-2026) (K L)
Table 133. Europe: Antiserum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Antiserum Sales Forecast by Region (2021-2026) (K L)
Table 135. Asia Pacific: Antiserum Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Antiserum Sales Forecast by Country (2021-2026) (K L)
Table 137. Latin America: Antiserum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Antiserum Sales Forecast by Country (2021-2026) (K L)
Table 139. Middle East and Africa: Antiserum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Antiserum Players
Table 144. Antiserum Customers List
Table 145. Antiserum Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Antiserum Product Picture
Figure 2. Global Antiserum Sales Market Share by Type in 2020 & 2026
Figure 3. Antitoxin Serum Product Picture
Figure 4. Antibacterial Serum Product Picture
Figure 5. Antiviral Serum Product Picture
Figure 6. Anti-Rh Serum Product Picture
Figure 7. Global Antiserum Sales Market Share by Application in 2020 & 2026
Figure 8. Laboratory
Figure 9. Clinical
Figure 10. Other
Figure 11. Antiserum Report Years Considered
Figure 12. Global Antiserum Market Size 2015-2026 (US$ Million)
Figure 13. Global Antiserum Sales 2015-2026 (K L)
Figure 14. Global Antiserum Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Antiserum Sales Market Share by Region (2015-2020)
Figure 16. Global Antiserum Sales Market Share by Region in 2019
Figure 17. Global Antiserum Revenue Market Share by Region (2015-2020)
Figure 18. Global Antiserum Revenue Market Share by Region in 2019
Figure 19. Global Antiserum Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2019
Figure 21. Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Antiserum Sales Market Share by Type (2015-2020)
Figure 23. Global Antiserum Sales Market Share by Type in 2019
Figure 24. Global Antiserum Revenue Market Share by Type (2015-2020)
Figure 25. Global Antiserum Revenue Market Share by Type in 2019
Figure 26. Global Antiserum Market Share by Price Range (2015-2020)
Figure 27. Global Antiserum Sales Market Share by Application (2015-2020)
Figure 28. Global Antiserum Sales Market Share by Application in 2019
Figure 29. Global Antiserum Revenue Market Share by Application (2015-2020)
Figure 30. Global Antiserum Revenue Market Share by Application in 2019
Figure 31. North America Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 32. North America Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Antiserum Sales Market Share by Country in 2019
Figure 34. North America Antiserum Revenue Market Share by Country in 2019
Figure 35. U.S. Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 36. U.S. Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 38. Canada Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Antiserum Market Share by Type in 2019
Figure 40. North America Antiserum Market Share by Application in 2019
Figure 41. Europe Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 42. Europe Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Antiserum Sales Market Share by Country in 2019
Figure 44. Europe Antiserum Revenue Market Share by Country in 2019
Figure 45. Germany Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 46. Germany Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 48. France Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 50. U.K. Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 52. Italy Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 54. Russia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Antiserum Market Share by Type in 2019
Figure 56. Europe Antiserum Market Share by Application in 2019
Figure 57. Asia Pacific Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 58. Asia Pacific Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Antiserum Sales Market Share by Region in 2019
Figure 60. Asia Pacific Antiserum Revenue Market Share by Region in 2019
Figure 61. China Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 62. China Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 64. Japan Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 66. South Korea Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 68. India Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 70. Australia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 72. Taiwan Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 74. Indonesia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 76. Thailand Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 78. Malaysia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 80. Philippines Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 82. Vietnam Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Antiserum Market Share by Type in 2019
Figure 84. Asia Pacific Antiserum Market Share by Application in 2019
Figure 85. Latin America Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 86. Latin America Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Antiserum Sales Market Share by Country in 2019
Figure 88. Latin America Antiserum Revenue Market Share by Country in 2019
Figure 89. Mexico Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 90. Mexico Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 92. Brazil Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 94. Argentina Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Antiserum Market Share by Type in 2019
Figure 96. Latin America Antiserum Market Share by Application in 2019
Figure 97. Middle East and Africa Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 98. Middle East and Africa Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Antiserum Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Antiserum Revenue Market Share by Country in 2019
Figure 101. Turkey Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 102. Turkey Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 104. Saudi Arabia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 106. U.A.E Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Antiserum Market Share by Type in 2019
Figure 108. Middle East and Africa Antiserum Market Share by Application in 2019
Figure 109. Charles River Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. SSI Diagnostica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. GD Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Novacyt Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. OriGene Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bethyl Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. FUJIFILM Wako Pure Chemical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Thermo Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 120. North America Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 122. Europe Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 124. Asia Pacific Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 126. Latin America Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 128. Middle East and Africa Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
Figure 1. Antiserum Product Picture
Figure 2. Global Antiserum Sales Market Share by Type in 2020 & 2026
Figure 3. Antitoxin Serum Product Picture
Figure 4. Antibacterial Serum Product Picture
Figure 5. Antiviral Serum Product Picture
Figure 6. Anti-Rh Serum Product Picture
Figure 7. Global Antiserum Sales Market Share by Application in 2020 & 2026
Figure 8. Laboratory
Figure 9. Clinical
Figure 10. Other
Figure 11. Antiserum Report Years Considered
Figure 12. Global Antiserum Market Size 2015-2026 (US$ Million)
Figure 13. Global Antiserum Sales 2015-2026 (K L)
Figure 14. Global Antiserum Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Antiserum Sales Market Share by Region (2015-2020)
Figure 16. Global Antiserum Sales Market Share by Region in 2019
Figure 17. Global Antiserum Revenue Market Share by Region (2015-2020)
Figure 18. Global Antiserum Revenue Market Share by Region in 2019
Figure 19. Global Antiserum Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2019
Figure 21. Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Antiserum Sales Market Share by Type (2015-2020)
Figure 23. Global Antiserum Sales Market Share by Type in 2019
Figure 24. Global Antiserum Revenue Market Share by Type (2015-2020)
Figure 25. Global Antiserum Revenue Market Share by Type in 2019
Figure 26. Global Antiserum Market Share by Price Range (2015-2020)
Figure 27. Global Antiserum Sales Market Share by Application (2015-2020)
Figure 28. Global Antiserum Sales Market Share by Application in 2019
Figure 29. Global Antiserum Revenue Market Share by Application (2015-2020)
Figure 30. Global Antiserum Revenue Market Share by Application in 2019
Figure 31. North America Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 32. North America Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Antiserum Sales Market Share by Country in 2019
Figure 34. North America Antiserum Revenue Market Share by Country in 2019
Figure 35. U.S. Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 36. U.S. Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 38. Canada Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Antiserum Market Share by Type in 2019
Figure 40. North America Antiserum Market Share by Application in 2019
Figure 41. Europe Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 42. Europe Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Antiserum Sales Market Share by Country in 2019
Figure 44. Europe Antiserum Revenue Market Share by Country in 2019
Figure 45. Germany Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 46. Germany Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 48. France Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 50. U.K. Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 52. Italy Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 54. Russia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Antiserum Market Share by Type in 2019
Figure 56. Europe Antiserum Market Share by Application in 2019
Figure 57. Asia Pacific Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 58. Asia Pacific Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Antiserum Sales Market Share by Region in 2019
Figure 60. Asia Pacific Antiserum Revenue Market Share by Region in 2019
Figure 61. China Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 62. China Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 64. Japan Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 66. South Korea Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 68. India Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 70. Australia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 72. Taiwan Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 74. Indonesia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 76. Thailand Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 78. Malaysia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 80. Philippines Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 82. Vietnam Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Antiserum Market Share by Type in 2019
Figure 84. Asia Pacific Antiserum Market Share by Application in 2019
Figure 85. Latin America Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 86. Latin America Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Antiserum Sales Market Share by Country in 2019
Figure 88. Latin America Antiserum Revenue Market Share by Country in 2019
Figure 89. Mexico Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 90. Mexico Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 92. Brazil Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 94. Argentina Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Antiserum Market Share by Type in 2019
Figure 96. Latin America Antiserum Market Share by Application in 2019
Figure 97. Middle East and Africa Antiserum Sales Growth Rate 2015-2020 (K L)
Figure 98. Middle East and Africa Antiserum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Antiserum Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Antiserum Revenue Market Share by Country in 2019
Figure 101. Turkey Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 102. Turkey Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 104. Saudi Arabia Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Antiserum Sales Growth Rate (2015-2020) (K L)
Figure 106. U.A.E Antiserum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Antiserum Market Share by Type in 2019
Figure 108. Middle East and Africa Antiserum Market Share by Application in 2019
Figure 109. Charles River Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. SSI Diagnostica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. GD Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Novacyt Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. OriGene Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bethyl Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. FUJIFILM Wako Pure Chemical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Thermo Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 120. North America Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 122. Europe Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 124. Asia Pacific Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 126. Latin America Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Antiserum Sales Growth Rate Forecast (2021-2026) (K L)
Figure 128. Middle East and Africa Antiserum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
